About

I am a computational structural biologist with a keen interest in protein design, currently working as a Doctoral Research Fellow in Immunology at the University of Oslo. You can find a brief summary of my previous experience below, along with more detailed information on my LinkedIn profile and CV.

• In 2017, I enrolled at the Faculty of Bioengineering and Bioinformatics at Lomonosov Moscow State University. Soon after, I realized that science was more important to me than attending classes, so I devoted most of my time and energy to research.
• From 2018 to 2021, I worked in the Virtual Structural Biology Group, where I studied cardiovascular diseases. There, I learned molecular modeling and the structural biology of proteins and nucleic acids.
• In 2020, I decided to broaden my horizons to Alzheimer’s disease by investigating the effect of ions on the aggregation of amyloid fibrils in the Strodel group at Forschungszentrum Jülich IBI-7.
• In 2021, I joined Sergey Ovchinnikov’s lab at Harvard with a focus on machine learning approaches in structural biology. My research involved studying AlphaFold2 in the context of de novo designed proteins.
• From 2021 to 2023, I was a part of Victor Greiff’s lab in Oslo, where I participated in numerous projects related to structural immunoinformatics, with a particular emphasis on antibody developability and design. Simultaneously, I collaborated with Shuguang Zhang at the Laboratory of Molecular Architecture at MIT, engaging in computational engineering of water-soluble membrane proteins using various bioinformatics methods.
• In 2022, I was employed by Biosim.AI, where I enhanced my industrial skills and learned how biotech companies combine molecular dynamics, artificial intelligence, and quantum chemistry to accelerate the drug design process.
• In 2023, I was accepted into the University of Oxford for a fully funded DPhil position in the computational biology program. The course, known as SABS R3, combines the development of software development skills with a research project. I chose to apply protein design for nanopore engineering under the supervision of Yujia Qing’s supervision in the Bayley group.
• In 2024, I couldn’t received UK visa to come to Oxford and switched to a PhD position at the University of Oslo. My research in Greiff lab focuses on improving antibody-antigen structure modeling accuracy to understand the rules behind their binding.

Beyond science, I like horses, music,​​ and design :)